L'invention se rapporte a des agents agonistes a base d'analogues d'amyline et a des compositions pharmaceutiques associees, a des procedes de traitement du diabete et d'autres etats necessitant l'administration d'insuline, ainsi qu'a des procedes de traitement de l'hypoglycemie.
howard jones合作论文数5Laura S.L. Gaeta合作论文数5Laura S. Lehman de Gaeta合作论文数2SB DANIELS合作论文数1Gjs Cooper合作论文数1
David C. Richardson合作论文数Department of Biochemistry, Duke University School of Medicine1
Jane S. Richardson合作论文数Department of Biochemistry, School of Medicine, Duke University;Basic Science Departments, School of Medicine, Duke University1
Hugh R.A. Jones合作论文数Science Technology Research Institute, University of Hertfordshire;Centre for Astrophysics Research, Department of Physics, Astronomy and Mathematics, School of Physics, Engineering and Computer Science, University of Hertfordshire1Bruce W. Erickson合作论文数1Kevin Beaumont合作论文数1Kathryn S. Prickett合作论文数1
